ArticleJournal of veterinary internal medicine2019

Evaluation of serum thymidine kinase 1 activity as a biomarker for treatment effectiveness and prediction of relapse in dogs with non-Hodgkin lymphoma.

Pierre Boyé et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.